Doctors weren't sure what was going on with the child, and their routine tests for bacterial causes of the rash, as well as viruses including chickenpox, HIV, and herpes all came back negative.

IvIG was repeated 2 weeks later at a reduced dose of 5 g/day for 5 days, repeated 4 weeks later. The Hb was stable above 90 g/l and the platelet count remained above 40 × 10 9 /l from ...

IVIg is expensive and has some toxicity, including risk for thrombosis and renal injury; [4] therefore, more data from controlled trials are needed before we can be certain of its precise role in ...

Recombinant IVIG granted Orphan Drug Designation for CIDP Lea Eslava-Kim, PharmD | August 10, 2015 ...

The IVIg was typically administered in monthly infusions of 2 g/kg over either 2 or 5 days, and the median duration of IVIg treatment was 7 months (range 2-32 months) with follow-up ranging from 3 ...

The investigators also observed a significantly lower risk for use of second-line therapy in the IVIG and methylprednisolone group (absolute risk difference, −0.22; OR, 0.19), along with a lower ...

High-dose intravenous immunoglobulin (IVIG) has been used for the treatment of autoantibody-mediated autoimmune diseases, but the molecular mechanism behind its anti-inflammatory effect was ...

“IVIG is the central therapy for patients with Kawasaki disease and should be administered as soon as the diagnosis of Kawasaki disease is made,” Mark Gorelik, MD, said in the release.